Dynamic Technology Lab’s Novavax NVAX Stock Holding History

Dynamic Technology Lab’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-906	Closed	-$131K	–	1039
2015 Q3	$131K	Buy	+906	New	+$203K	0.04%	726
2014 Q4	–	Sell	-1,053	Closed	-$88K	–	804
2014 Q3	$88K	Buy	+1,053	New	+$95.2K	0.04%	581
2013 Q4	–	Sell	-1,523	Closed	-$96K	–	658
2013 Q3	$96K	Buy	+1,523	New	+$85.8K	0.08%	419

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dynamic Technology Lab's NVAX Position: Q4 2015 in Review

Dynamic Technology Lab sold out of Novavax (NVAX) in Q4 2015, closing a stake of 906 shares — an estimated $131K sold.

Dynamic Technology Lab first reported a position in NVAX in Q3 2013 and held it in 3 quarters. The position peaked at $131K in Q3 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

Dynamic Technology Lab reported no remaining Novavax position as of Q4 2015 after selling out during the quarter.
Dynamic Technology Lab sold 906 Novavax shares in Q4 2015, an estimated $131K.
Dynamic Technology Lab first reported a position in Novavax in Q3 2013 and held it in 3 quarters.
Dynamic Technology Lab's Novavax position peaked at $131K in Q3 2015.
173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on Dynamic Technology Lab's 13F filing for Q4 2015, filed 11 Feb 2016.